药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Haloprogin
Ferric oxyhydroxide
Ferric oxyhydroxide can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Calcium polycarbophil
Calcium polycarbophil can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Lanthanum III cation
Lanthanum III cation can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Tetraferric tricitrate decahydrate
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Ferric pyrophosphate citrate
Ferric pyrophosphate citrate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Ferric cation
Ferric cation can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Ferric sulfate
Ferric sulfate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Calcium gluconate
Calcium gluconate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Calcium citrate
Calcium citrate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Sodium ferric gluconate complex
Sodium ferric gluconate complex can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Ferric pyrophosphate
Ferric pyrophosphate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Iron sucrose
Iron sucrose can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Ferric carboxymaltose
Ferric carboxymaltose can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Lanthanum carbonate
Lanthanum carbonate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Calcium carbonate
Calcium carbonate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Calcium
Calcium can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Calcium chloride
Calcium chloride can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Iron Dextran
Iron Dextran can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Pralsetinib
Pralsetinib may decrease the excretion rate of Ofloxacin which could result in a higher serum level.
Haloprogin
Valinomycin
Valinomycin may decrease the excretion rate of Ofloxacin which could result in a higher serum level.